Davion Healthcare director buys 10,000 common shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4/A
Rhea-AI Filing Summary
Davion Healthcare PLC (DAVI) director Susan M. King reported a direct purchase of 10,000 common shares at $0.98 per share on November 17, 2026. Her direct holdings were 15,000 shares after the purchase.
Insider Trade Summary
Net Buyer: 10,000 shares
Net Buy
1 txn
Insider
King Susan M
Role
Director
Bought
10,000 shs ($10K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 10,000 | $0.98 | $10K |
Holdings After Transaction:
Common Stock — 15,000 shares (Direct)
Key Figures
Shares purchased: 10,000 shares
Purchase price: $0.98 per share
Direct holdings after purchase: 15,000 shares
3 metrics
Shares purchased
10,000 shares
November 17, 2026
Purchase price
$0.98 per share
Purchase on November 17, 2026
Direct holdings after purchase
15,000 shares
Following the November 17, 2026 purchase
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.